Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04881240
Title Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

leukemia

Therapies

CD19-CAR(Mem) T-cells + Cyclophosphamide + Fludarabine + Mesna

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.